chalcone has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavasiri, W; Danova, A; Jutabha, P; Muanprasat, C; Noitem, R; Poolsri, W; Raveesunthornkiat, M | 1 |
| OSTERMAN, FA | 1 |
2 other study(ies) available for chalcone and Chronic Kidney Diseases
| Article | Year |
|---|---|
Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis.
Topics: Animals; Antifibrotic Agents; Chalcone; Chalcones; Fibrosis; Kidney; Kidney Diseases; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction | 2023 |
Hesperidin-methylene-carboxy-chalcone in chronic kidney diseases.
Topics: Chalcone; Flavones; Hesperidin; Humans; Kidney Diseases; Methane; Renal Insufficiency, Chronic | 1957 |